Similar articles

• Interleukin-HP1-related hybridoma and plasmacytoma growth factors induced by lipopolysaccharide in vivo.

  Coulie PG, Cayphas S, Vink A, Uyttenhove C, Van Snick J. Coulie PG, et al. Eur J Immunol. 1987 Aug;17(8):1217-20. doi: 10.1002/eji.1830170821. Eur J Immunol. 1987. PMID: 3305041
• Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas.

  Bazin R, Lemieux R. Bazin R, et al. J Immunol. 1987 Aug 1;139(3):780-7. J Immunol. 1987. PMID: 3496390
• Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.

  Schwabe M, Cox GW, Bosco MC, Prohaska R, Kung HF. Schwabe M, et al. Cell Immunol. 1996 Feb 25;168(1):117-21. doi: 10.1006/cimm.1996.0056. Cell Immunol. 1996. PMID: 8599834
• Cytokines as autocrine growth factors in malignancies.

  Kawano M, Kuramoto A, Hirano T, Kishimoto T. Kawano M, et al. Cancer Surv. 1989;8(4):905-19. Cancer Surv. 1989. PMID: 2701735 Review.
• Molecular biology of T-cell-derived lymphokines: a model system for proliferation and differentiation of hemopoietic cells.

  Arai K, Yokota T, Miyajima A, Arai N, Lee F. Arai K, et al. Bioessays. 1986 Oct;5(4):166-71. doi: 10.1002/bies.950050407. Bioessays. 1986. PMID: 3333472 Review. No abstract available.